- Forums
- ASX - By Stock
- NEU
- Ann: NEU confirms primary endpoints for Phase 3 trial in PMS
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.49%
!
$14.13

Ann: NEU confirms primary endpoints for Phase 3 trial in PMS, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.13 |
Change
-0.070(0.49%) |
Mkt cap ! $1.753B |
Open | High | Low | Value | Volume |
$14.23 | $14.71 | $14.03 | $3.459M | 242.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 258 | $14.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.14 | 196 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 513 | 14.100 |
13 | 532 | 14.090 |
5 | 629 | 14.080 |
9 | 1013 | 14.070 |
5 | 1178 | 14.060 |
Price($) | Vol. | No. |
---|---|---|
14.110 | 283 | 7 |
14.120 | 525 | 3 |
14.130 | 1394 | 9 |
14.140 | 1239 | 5 |
14.150 | 1484 | 7 |
Last trade - 14.16pm 30/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |